Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2011-11-30
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery
NCT05518292
Ultrasound-Guided Serratus Plane Block Vs Paravertebral Block For Chronic Post-mastectomy Pain.
NCT04317898
Analgesic Efficacy of Ultrasound Guided Serratus Anterior Plane Block and Pectoral Nerve Block II
NCT06188156
Ultrasound Guided Versus Standard Paravertebral Blockade in Breast Surgery
NCT02623387
TPVB, PECSB, ESPB for Postmastectmy Pain
NCT05076773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We compared a single injection thoracic PVB with general anaesthesia (GA) in 20 consenting patients, scheduled for unilateral breast surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TPVB group
In this group of patients thoracic paravertebral block is performed.
No interventions assigned to this group
GA group
In this group of patients general anesthesia is performed.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Age older than 18 years old
Exclusion Criteria
* local sepsis
18 Years
90 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Campus Bio-Medico University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Massimiliano Carassiti
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Massimiliano Carassiti, MD
Role: PRINCIPAL_INVESTIGATOR
Campus Bio Medico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Campus Bio Medico
Rome, RM, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TPVB
Identifier Type: OTHER
Identifier Source: secondary_id
CarGal2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.